PATH
Menu

Filter browse results

Total results with these characteristics: 23

Subject: Emerging and epidemic diseases > Influenza
Publication date: All

Page 1 of 2
Ukraine Country Program Website

This website about PATH’s Ukraine country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2014

Region: Eastern Europe

Part of series: Program websites

Vaccine Development Global Program Website

This website about PATH’s Vaccine Development global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2014

Region: Global

Part of series: Program websites

Vaccines for the Future

Vaccines for the Future provides quarterly updates on our efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against pneumonia (pneumococcal disease) and diarrheal disease (rotavirus, Shigella, enterotoxigenic Escherichia coli), as well as new vaccines for the global population against influenza, meningitis, polio, and respiratory syncytial virus. It includes updates on our progress, partnerships, and specific activities related to these projects.

Publication date: 2014

Region: Global

Part of series: E-newsletters

Vietnam Country Program Website

This website about PATH’s Vietnam country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2014

Region: Asia

Part of series: Program websites

Advancing New Technologies Against Influenza

This fact sheet highlights PATH's work to advance the development of new vaccines against influenza that are affordable and accessible for the developing world.

Publication date: October 2013

Region: Global

Expanding Vaccine Solutions Against Influenza

This fact sheet highlights PATH's multifaceted approach to expanding vaccine solutions against influenza that are optimal for the developing world. It describes our efforts to advance the development of promising new influenza vaccines, gain a better understanding of influenza vaccine performance in children in low-resource countries, and help emerging-country manufacturers produce influenza vaccines for pandemic preparedness.

Publication date: October 2013

Region: Global

Increasing Vaccine Supply to Protect Against Influenza

This fact sheet describes a project that PATH is implementing in collaboration with the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services. The project is supporting the enhancement of sustainable influenza vaccine production in Vietnam. PATH is collaborating with various groups in Vietnam to facilitate the production and clinical evaluation of safe and effective influenza vaccines and synergizing activities with work already under way in Vietnam through the World Health Organization.

Publication date: October 2013

Region: Asia

Stabilizing Influenza Vaccines

If a highly virulent pandemic strain were to emerge in today’s interconnected world, influenza has the potential to kill millions of people, especially in developing countries with limited to no resources for pandemic planning, preparedness, and outbreak response. PATH's work in developing thermostable influenza vaccines holds promise for extending product shelf life and easing logistics during introduction and rapid deployment to hard-to-reach populations—markedly improving developing-country preparedness and ability to contain the virus at its point of origin. This fact sheet describes our latest research achievements and next steps in product development.

Publication date: September 2013

Region: Global

Investigating Live Attenuated Influenza Vaccine Efficacy in Senegal

This fact sheet describes a phase 3 clinical study that PATH and our partners are conducting in Senegal to evaluate the clinical efficacy of a seasonal, trivalent live attenuated influenza vaccine (LAIV). By providing evidence on how well this type of vaccine works among young children in Senegal, this study will help inform efforts in the scientific community to develop optimal LAIVs for the world’s most vulnerable children, as well as policy decisions for potential future LAIV use in Senegal and other tropical, low-resource countries in Africa.

Publication date: May 2013

Region: Africa

Understanding Influenza Vaccine Performance Among Children in Senegal

This fact sheet describes a phase 2 influenza vaccine clinical study that PATH and our partners are conducting in Senegal. The study seeks to better understand the performance of seasonal influenza vaccines in a tropical, low-resource region of the country. Overall, the results from this study will provide evidence to support larger research efforts to determine the most feasible and efficient ways of protecting populations in tropical, developing Africa from influenza through the use of vaccines.

Publication date: April 2013

Region: Africa

Reducing the Burden of Disease: PATH Provides Tools and Expertise to Address Global Health Threats

This fact sheet summarizes PATH's work to curb emerging and epidemic diseases such as HIV/AIDS, tuberculosis, and malaria. Topic areas include advancing technologies to improve prevention, diagnosis, and treatment; strengthening health systems; encouraging healthy behaviors; and mobilizing and supporting our partners.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

Directions in Global Health (Volume 8, Issue 2)

This issue of Directions in Global Health features PATH’s work to address noncommunicable diseases, such as diabetes and cancer. It also covers efforts to improve health in Kenya, build global and country capacity for influenza control, improve gender equity in China, and integrate health services for better outcomes.

Publication date: December 2011

Region: Global

Part of series: Directions in Global Health

PATH Today (Winter 2011)

This issue of PATH Today features our work in vaccines, with a focus on how PATH is making "hidden solutions" available, and describes lifesaving changes in South Africa's infant feeding policies. It also includes news from our malaria and meningitis work, an announcement of PATH's new blog, and a profile of PATH donor Lora Kaiser.

Publication date: December 2011

Region: Global

Part of series: PATH Today

Understanding Influenza Vaccine Effectiveness in Senegal

This fact sheet describes a phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, as well as the potential of current seasonal influenza vaccines to reduce influenza-related deaths in the developing world. Ultimately, study data could help public health officials decide how to best use influenza vaccines in Senegal and in similar tropical countries.

Publication date: May 2011

Region: Africa

PATH Today (Fall 2009)

This edition of PATH Today highlights work to improve children’s health in Nicaragua and Kenya and spotlights PATH's safe water project in Korogocho, a slum near Nairobi, Kenya. It also includes brief updates on the 2009 Breakfast for Global Health, workplace giving, an influenza vaccine study in Africa, and PATH's 2008 annual report.

Publication date: September 2009

Region: Global

Part of series: PATH Today

Directions in Global Health (Volume 6, Issue 2)

This issue of Directions in Global Health showcases PATH’s global presence. It highlights work related to influenza in Africa, HIV and AIDS in Eastern Europe,  Japanese encephalitis in Asia, gender-based violence in Latin America and the Caribbean, and diagnostic technologies in North America. The back cover features a map and summary information on PATH’s work around the world.

Publication date: August 2009

Region: Global

Part of series: Directions in Global Health

Ukraine Health Services Response to Pandemic Influenza: Provisional Guidelines for Ukraine's Health Services to Plan and Organize Measures to Combat Pandemic Influenza

This document provides the overall framework and specific operational procedures for Ukraine’s health sector response to an influenza pandemic. Its prime objectives are to reduce the health impact of a pandemic and minimize disruption to health and other essential services while maintaining business continuity and reducing the disruption to society.

Publication date: July 2009

Region: Global

Surveillance and Control of Seasonal and Avian Influenza in Humans: Guidelines for Public Health Services in Ukraine (second edition)

Outbreaks of highly pathogenic avian influenza are occurring in domestic fowl in many countries, posing a considerable human public health risk. Based on the latest World Health Organization (WHO) standards and recommendations, this manual provides comprehensive recommendations to help Ukrainian health care workers establish sentinel site surveillance and promptly identify, report, confirm, and classify potential cases of avian influenza in humans. In addition, the document includes guidance on the basic parameters for surveillance data analysis, investigation of trigger cases and outbreaks, improvement of other aspects of an early warning system for humans, and communication with the public and infection-control professionals. The guidelines are most appropriate for the current and the next stages of pandemic preparedness (phases 3 and 4 of the WHO Pandemic Alert Period) and are designed primarily for health care personnel working at rayon and regional sanitary-epidemiological stations.

Publication date: July 2008

Region: Eastern Europe

Role of the Primary Care Providers in Early Detection and Response to Avian Influenza in Humans

This brochure provides recommendations for primary care providers on early detection and response to avian influenza in humans.

Publication date: June 2008

Region: Eastern Europe

Influenza Vaccine Strategies for Broad Global Access

Influenza viruses present one of the major infectious disease threats to the human population, with the recently emerging, highly pathogenic avian influenza strain, H5N1, causing particular concern. A virulent influenza pandemic has the potential to kill more than 100 million people worldwide. This paper analyzes the current supply of influenza vaccines, the predicted demand for influenza vaccines in case of a pandemic, and new vaccine technologies that could provide for the world’s demand in a pandemic situation.

Author: Oliver Wyman

Publication date: October 2007

Region: Global

Page 1 of 2